ID: ALA5267520

Max Phase: Preclinical

Molecular Formula: C17H15BrO3

Molecular Weight: 347.21

Associated Items:

Representations

Canonical SMILES:  COc1ccc(/C=C/C(=O)c2ccc(O)c(C)c2)cc1Br

Standard InChI:  InChI=1S/C17H15BrO3/c1-11-9-13(5-7-15(11)19)16(20)6-3-12-4-8-17(21-2)14(18)10-12/h3-10,19H,1-2H3/b6-3+

Standard InChI Key:  FQGVESCZSZNDMF-ZZXKWVIFSA-N

Associated Targets(non-human)

Bacillus anthracis 2936 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 347.21Molecular Weight (Monoisotopic): 346.0205AlogP: 4.37#Rotatable Bonds: 4
Polar Surface Area: 46.53Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.24CX Basic pKa: CX LogP: 4.71CX LogD: 4.65
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.66Np Likeness Score: 0.13

References

1. Dan W, Dai J..  (2020)  Recent developments of chalcones as potential antibacterial agents in medicinal chemistry.,  187  [PMID:31877539] [10.1016/j.ejmech.2019.111980]

Source